Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...

For the past several years, physicians and compounding pharmacies have stepped in to address critical patient access gaps during U.S. Food and Drug Administration (FDA) shortage declarations for ...

Lanxess, a glass fiber manufacturers, is seeing a marked growth in demand for its milled short glass fibers (milled fiber) for plastic compounding, but not only. This is particularly true for the ...

What motivated the shift into the veterinary space? Topelius: Actually, we started with veterinary applications. When we founded the company, our first application areas w ...